Ticker > Company >

Abbott India share price

Abbott India Ltd.

NSE: ABBOTINDIA BSE: 500488 SECTOR: Pharmaceuticals & Drugs  183k   1k   145

31650.00
+174.60 (0.55%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 31650

Today's Low

₹ 31125.05

52 Week High

₹ 32229.25

52 Week Low

₹ 25260.2

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

67254.04 Cr.

Enterprise Value

65119.55 Cr.

No. of Shares

2.12 Cr.

P/E

47.55

P/B

15.89

Face Value

₹ 10

Div. Yield

1.5 %

Book Value (TTM)

₹  1992.14

CASH

2134.49 Cr.

DEBT

0 Cr.

Promoter Holding

74.99 %

EPS (TTM)

₹  665.64

Sales Growth

9.35%

ROE

35.31 %

ROCE

47.34%

Profit Growth

26.52 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Abbott India Ltd.

BRUFEN Digene DUPHALAC Zolfresh Cremaffin Solspre Cremalax Ganaton LIBRAX THYROCAB Eptoin OBIMET SOLFE Wymox Thyronorm Duphaston Vertin Udiliv Heptral Prothiaden Stemetil Haemaccel Kenacort Paraxin Neomercazole Betonin Plus Syrup Arachitol Nano Ensure Similac

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year9.35%
3 Year10.71%
5 Year9.72%

Profit Growth

1 Year26.52%
3 Year20.26%
5 Year21.68%

ROE%

1 Year35.31%
3 Year32.44%
5 Year30.46%

ROCE %

1 Year47.34%
3 Year43.6%
5 Year40.97%

Debt/Equity

0

Price to Cash Flow

55.45

Interest Cover Ratio

130.9398

CFO/PAT (5 Yr. Avg.)

1.04105411119905

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 74.99 0.00
Dec 2024 74.99 0.00
Sep 2024 74.99 0.00
Jun 2024 74.99 0.00
Mar 2024 74.99 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 20.2577651567425% for the Past 3 years.
  • Company has been maintaining healthy ROE of 32.4404005809797% over the past 3 years.
  • Company has been maintaining healthy ROCE of 43.6017165641513% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 130.9398.
  • The Company has been maintaining an effective average operating margins of 21.3093032132571% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -49.798 days.
  • Company has a healthy liquidity position with current ratio of 2.4174.
  • The company has a good cash flow management; CFO/PAT stands at 1.04105411119905.
  • The company has a high promoter holding of 74.99%.

 Limitations

  • The company has shown a poor revenue growth of 10.7128700036431% for the Past 3 years.
  • The company is trading at a high PE of 47.55.
  • The company is trading at a high EV/EBITDA of 33.3097.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 1438.63 1557.61 1632.67 1614.28 1604.59
Total Expenditure 1109.1 1166.6 1193.71 1178.19 1176.05
Operating Profit 329.53 391.01 438.96 436.09 428.54
Other Income 81.15 67.33 60.48 71.75 76.02
Interest 2.81 2.75 2.5 2.26 3.92
Depreciation 18.19 18.37 17.51 17.99 17.93
Exceptional Items 0 0 0 0 0
Profit Before Tax 389.68 437.22 479.43 487.59 482.71
Tax 102.62 109.21 120.82 126.81 115.67
Profit After Tax 287.06 328.01 358.61 360.78 367.04
Adjusted EPS (Rs) 135.09 154.36 168.76 169.78 172.72

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 4093.14 4310.02 4913.32 5348.73 5848.91
Total Expenditure 3336.96 3391.13 3831.74 4143.24 4395.86
Operating Profit 756.18 918.89 1081.58 1205.49 1453.05
Other Income 114.66 83.47 83.35 154.29 248.32
Interest 8.53 18.28 19.1 15.99 12.45
Depreciation 59.61 58.13 66.1 69.97 71.17
Exceptional Items 0 0 0 0 0
Profit Before Tax 802.7 925.95 1079.73 1273.82 1617.75
Tax 209.77 235.26 281.03 324.41 416.53
Net Profit 592.93 690.69 798.7 949.41 1201.22
Adjusted EPS (Rs.) 279.03 325.03 375.86 446.78 565.28

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 21.25 21.25 21.25 21.25 21.25
Total Reserves 2410.45 2580.91 2798.54 3167.29 3677.64
Borrowings 0 0 0 0 0
Other N/C liabilities 209.6 189.62 184.18 144.02 136.03
Current liabilities 891.11 1030.86 1203.19 1206.02 1342.72
Total Liabilities 3532.41 3822.64 4207.16 4538.58 5177.64
Assets
Net Block 269.83 250.78 271 236.91 224.94
Capital WIP 1.64 0.66 0.66 3.66 10.11
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 50.91 78.8 79.35 97.88 80.18
Other N/C Assets 5.38 4.99 3.11 1175.02 1616.57
Current Assets 3204.65 3487.41 3853.04 3025.11 3245.84
Total Assets 3532.41 3822.64 4207.16 4538.58 5177.64
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 802.7 925.95 1079.73 1273.82 1617.75
Adjustment -17.22 24.99 23.3 -62.7 -129.85
Changes in Assets & Liabilities 69.82 11.26 133.62 23.13 129.38
Tax Paid -229.17 -235.46 -288.99 -340.86 -404.47
Operating Cash Flow 626.13 726.74 947.66 893.39 1212.81
Investing Cash Flow -401.21 -71.82 -395.84 -147.71 -416.03
Financing Cash Flow -216.79 -581.79 -637.38 -638.72 -744.71
Net Cash Flow 8.13 73.13 -85.56 106.96 52.07

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 74.99 74.99 74.99 74.99 74.99
abbott capital india limi... 50.44 50.44 50.44 50.44 50.44
abbott healthcare product... 17.62 17.62 17.62 17.62 17.62
british colloids limited 6.92 - 6.92 6.92 6.92
british colloids ltd - 6.92 - - -
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 25.01 25.01 25.01 25.01 25.01
canara robeco mutual fund... 1.25 1.43 - 1.23 1.15
investor education and pr... 0.49 - 0.54 - 0.53
sbi retirement benefit fu... - - - - 2.72
investor education and pr... - 0.49 - 0.54 -
sbi long term advantage f... - - - 2.76 -
canara robeco mutual fund... - - 1.26 - -
sbi arbitrage opportuniti... - 2.20 2.58 - -
sbi nifty midcap 150 inde... 1.88 - - - -

Annual Reports

Title Action
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY ACTION
No Credit reports exist for this company.Report us
TYPE AGENCY ACTION
Research BOB Capital Market
Research BOB Capital Market
Research ICICI Securities Limited

Concalls & Presentations

TYPE QUARTER ACTION
Currently we do not have any Concall related to this company.Report us
TYPE QUARTER ACTION
Currently we do not have any Presentation related to this company.Report us

Company News

Abbott India Stock Price Analysis and Quick Research Report. Is Abbott India an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Abbott India and its performance over the period of time. Abbott India stock price today is Rs 31515.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Abbott India cash from the operating activity was Rs 1212.81 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Abbott India has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Abbott India , the EPS growth was 26.5228 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Abbott India has OPM of 24.8430904219761 % which is a good sign for profitability.
     
  • ROE: Abbott India have a healthy ROE of 35.3053 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Abbott India is Rs 31515. One can use valuation calculators of ticker to know if Abbott India share price is undervalued or overvalued.
Last Updated on:
Brief about Abbott India
X